Eli Lilly

AbbVie

Bristol-Myers

Amgen

Johnson & Johnson

Alnylam Pharmaceuticals

Pfizer

Alkermes

Merck

Regeneron Pharmaceuticals

Horizon Kinetics Medical ETF

MEDX actively invests in global companies within the broad health care sector. Stock selection and weighting emphasizes those invested in cancer research and pharmaceutical developments.

iShares U.S. Pharmaceuticals ETF

iShares U.S. Healthcare ETF

VanEck Vectors Pharmaceutical ETF

Health Care Select Sector SPDR Fund

Eli Lilly and Company (LLY) raised its outlook for 2024 on rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro.

ETFs to Buy as Eli Lilly Beats Q1 Earnings, Lifts Outlook

Harbor Health Care ETF

Eli Lilly and Company (LLY) posted robust fourth-quarter 2023 earnings, beating estimates on both the top and bottom lines driven by strong sales of its diabetes and weight-loss treatments.

ETFs to Buy as Mounjaro Powers Eli Lilly's Q4 Earnings Beat

Eli Lilly (LLY) posted robust third-quarter 2023 earnings results, beating estimates on both the top and bottom lines. Its Mounjaro anti-obesity drug continued its robust performance.

Eli Lilly Beats on Q3 Earnings: ETFs to Buy

Eli Lilly (LLY) experienced its most significant surge in stock prices in over two decades following the release of an impressive second-quarter 2023 earnings report and an optimistic outlook. ETFs having the largest exposure to the drug maker could be compelling picks to tap the strong growth.

Eli Lilly Soars on Blockbuster Q2 Earnings: ETFs to Tap

VanEck Vectors Biotech ETF

First Trust Morningstar Dividend Leaders Index Fund

First Trust Nasdaq Pharmaceuticals ETF 

Amplify Treatments Testing & Advancements ETF

iShares Core High Dividend ETF

Invesco Nasdaq Biotechnology ETF

Moderna

Novavax

Invesco Dynamic Pharmaceuticals ETF

The FDA advised to Pfizer, Moderna and Novavax to manufacture single-strain jabs targeting the omicron subvariant XBB.1.5 should prove to be a victory for some biotech ETFs.

Biotech ETFs in Focus on Covid Vaccines' Fall Rollout

DiCE Molecules Holding LLC

Eli Lilly (LLY) has agreed to acquire DICE Therapeutics (DICE) in a cash deal worth approximately $2.4 billion. This strategic move is part of Eli Lilly's efforts to bolster its immunology pipeline, specifically targeting immune disease-related treatments.

ETFs to Capitalize on Eli Lilly's Buyout of DICE Therapeutics

Colliers International Group

Sunoco

The Oakmark Intl Small Cap (Trades, Portfolio) Fund recently disclosed its portfolio updates on its website for the fiscal quarter ended March 31. The company's fiscal year ends on Sept.

3 Value Picks From the Oakmark International Small Cap Fund

Horizon Kinetics Spac Active ETF

NEW YORK, NY / ACCESSWIRE / January 30, 2023 / Horizon Kinetics LLC today launched the Horizon Kinetics SPAC Active ETF (NASDAQ:SPAQ) and the Horizon Kinetics Medical ETF (NASDAQ:MEDX). SPAQ was converted from the Kinetics Alternative Income Mutual Fund, and MEDX from the Kinetics Medical Mutual Fund, as part of tax-free reorganizations effective after the close of business on January 27, 2023.

Horizon Kinetics Launches the Horizon Kinetics SPAC Active ETF (SPAQ) and the Horizon Kinetics Medical ETF (MEDX)

News for Horizon Kinetics Medical ETF ETF (MEDX)